Investments
29Funds
2Partners & Customers
1About Heritas Capital
Heritas Capital is a Singapore-based private equity and venture capital investment firm that invests in fast-growing companies and leading funds across the healthcare, education and technology sectors.
Heritas Capital Headquarter Location
9 Temasek Boulevard #11-01 Suntec Tower Two
038989,
Singapore
+65 6716 0500
Latest Heritas Capital News
Jun 13, 2022
Tessa Therapeutics, a Singapore-based cell therapy business that conducts cancer research, has secured $126 million in a series of funding rounds. Polaris Partners, a healthcare investment business, led the fundraising round. Existing investors such as Singapore’s state-owned investors Temasek, EDBI, Heliconia Capital, and Heritas Capital also participated in the round. Amy Schulman and Darren Carroll, managing partners at Polaris Partners, have joined Tessa’s board of directors in conjunction with the funding. The money will go toward the company’s continuing clinical trials for its treatment approaches. Tessa’s newly qualified commercial CGMP plant in Singapore will produce the clinical trial supplies. Tessa Therapeutics was founded in 2011 with the goal of developing next-generation cancer medicines for haematological malignancies and solid tumours. Temasek led an $80 million fundraising round in 2017, with participation from EDBI, Karst Peak Capital, Heliconia, and Heritas, among others.
Heritas Capital Investments
29 Investments
Heritas Capital has made 29 investments. Their latest investment was in Tessa Therapeutics as part of their Series A on June 6, 2022.
Heritas Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/9/2022 | Series A | Tessa Therapeutics | $126M | No | 2 | |
4/28/2022 | Seed VC | HealthBeats | $3M | Yes | 1 | |
1/12/2022 | Series B | Jio Health | $20M | Yes | 3 | |
12/9/2021 | Series B | |||||
12/6/2021 | Series B |
Date | 6/9/2022 | 4/28/2022 | 1/12/2022 | 12/9/2021 | 12/6/2021 |
---|---|---|---|---|---|
Round | Series A | Seed VC | Series B | Series B | Series B |
Company | Tessa Therapeutics | HealthBeats | Jio Health | ||
Amount | $126M | $3M | $20M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 1 | 3 |
Heritas Capital Fund History
2 Fund Histories
Heritas Capital has 2 funds, including Heritas Capital Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/30/2021 | Heritas Capital Fund II | $7.37M | 1 | ||
6/2/2021 | Heritas Capital Fund III |
Closing Date | 9/30/2021 | 6/2/2021 |
---|---|---|
Fund | Heritas Capital Fund II | Heritas Capital Fund III |
Fund Type | ||
Status | ||
Amount | $7.37M | |
Sources | 1 |
Heritas Capital Partners & Customers
1 Partners and customers
Heritas Capital has 1 strategic partners and customers. Heritas Capital recently partnered with Timberland Medical Centre on January 1, 2016.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
1/1/2016 | Client | Malaysia | `` Working closely with Timberland Medical Centre doctors and staff as well as local partners and stakeholders , Heritas Capital team is pleased to contribute to Timberland Medical Centre 's mission and purpose to provide more sustainable and inclusive healthcare solutions , '' said Chik Wai Chiew , Executive Director and CEO of Heritas Capital . | 1 |
Date | 1/1/2016 |
---|---|
Type | Client |
Business Partner | |
Country | Malaysia |
News Snippet | `` Working closely with Timberland Medical Centre doctors and staff as well as local partners and stakeholders , Heritas Capital team is pleased to contribute to Timberland Medical Centre 's mission and purpose to provide more sustainable and inclusive healthcare solutions , '' said Chik Wai Chiew , Executive Director and CEO of Heritas Capital . |
Sources | 1 |
Heritas Capital Team
1 Team Member
Heritas Capital has 1 team member, including current Managing Director, Ryan Chan.
Name | Work History | Title | Status |
---|---|---|---|
Ryan Chan | Managing Director | Current |
Name | Ryan Chan |
---|---|
Work History | |
Title | Managing Director |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.